Mycotopia Therapies (Mycotopia Therapies) Debt-to-Equity : -0.52 (As of Mar. 2024)

View and export this data going back to 2005. Start your Free Trial

What is Mycotopia Therapies Debt-to-Equity?

Mycotopia Therapies's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $1.27 Mil. Mycotopia Therapies's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was $0.00 Mil. Mycotopia Therapies's Total Stockholders Equity for the quarter that ended in Mar. 2024 was $-2.45 Mil. Mycotopia Therapies's debt to equity for the quarter that ended in Mar. 2024 was -0.52.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Mycotopia Therapies's Debt-to-Equity or its related term are showing as below:

TPIA' s Debt-to-Equity Range Over the Past 10 Years
Min: -7.81 Med: -0.57 Max: 14.4
Current: -0.52

During the past 6 years, the highest Debt-to-Equity Ratio of Mycotopia Therapies was 14.40. The lowest was -7.81. And the median was -0.57.

TPIA's Debt-to-Equity is not ranked
in the Healthcare Providers & Services industry.
Industry Median: 0.48 vs TPIA: -0.52

Mycotopia Therapies Debt-to-Equity Historical Data

The historical data trend for Mycotopia Therapies's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mycotopia Therapies Debt-to-Equity Chart

Mycotopia Therapies Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

-7.81

14.40

-0.74

-0.54

Mycotopia Therapies Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Debt-to-Equity	Get a 7-Day Free Trial															-0.66	-0.65	-0.60	-0.54	-0.52

Competitive Comparison of Mycotopia Therapies's Debt-to-Equity

For the Medical Care Facilities subindustry, Mycotopia Therapies's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Mycotopia Therapies's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Mycotopia Therapies's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Mycotopia Therapies's Debt-to-Equity falls into.

Mycotopia Therapies Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Mycotopia Therapies's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.091	+	0)	/	-2.028
	=	-0.54

Mycotopia Therapies's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(1.265	+	0)	/	-2.454
	=	-0.52

Mycotopia Therapies (OTCPK:TPIA) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Mycotopia Therapies Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Mycotopia Therapies's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Mycotopia Therapies (Mycotopia Therapies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mycotopia Therapies Inc (OTCPK:TPIA) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

18851 NE 29th Avenue, Suite 700, Aventura, FL, USA, 33180

Website

https://www.mycotopiatherapies.com

Mycotopia Therapies Inc provides psychedelic therapies through technology-focused, data-driven, and medical-based solutions for people dealing with anxiety, depression, bipolar disorders, PTSD, ADHD, autism, and addictions.

Executives

Mark D. Williams	director, 10 percent owner, officer: President, CEO & CFO	480 22ND STREET, BOX 2, HEYBURN ID 83336
Gibson Colin	director, 10 percent owner, officer: Vice President	480 22ND STREET, BOX 2, HEYBURN ID 83336